Antibody to oxidized low-density lipoprotein and cardiovascular mortality in end-stage renal disease
- 1 December 2002
- journal article
- Published by Elsevier in Kidney International
- Vol. 62 (6), 2230-2237
- https://doi.org/10.1046/j.1523-1755.2002.00692.x
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Ex vivo low-density lipoprotein oxidizability and in vivo lipid peroxidation in patients on CAPDKidney International, 2001
- Oxidized or acetylated low density lipoproteins are rapidly cleared by the liver in mice with disruption of the scavenger receptor class A type I/II gene.Journal of Clinical Investigation, 1997
- Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity.Journal of Clinical Investigation, 1995
- Transient reduction of autoantibodies against oxidized ldl in patients with acute myocardial infarctionFree Radical Biology & Medicine, 1995
- Patients With Early-Onset Peripheral Vascular Disease Have Increased Levels of Autoantibodies Against Oxidized LDLArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysisKidney International, 1994
- Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis?Kidney International, 1994
- Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Induction of T-cell activation by oxidized low density lipoprotein.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992